AAAAAA
Results: 1-25/26
Authors:
Foss, B
Ulvestad, E
Hervig, T
Bruserud, O
Citation: B. Foss et al., Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance inacute myelogenous leukemia, INT J CANC, 97(1), 2002, pp. 106-114
Authors:
Bruserud, O
Citation: O. Bruserud, Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia, INT IMMUNO, 1(12), 2001, pp. 2183-2195
Authors:
Foss, B
Mentzoni, L
Bruserud, O
Citation: B. Foss et al., Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts, J HEMATH ST, 10(1), 2001, pp. 81-93
Authors:
Bruserud, O
Foss, B
Petersen, H
Citation: O. Bruserud et al., Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L), EUR CYTOKIN, 12(2), 2001, pp. 231-238
Authors:
Bruserud, O
Gjertsen, BT
Foss, B
Huang, TS
Citation: O. Bruserud et al., New strategies in the treatment of acute myelogenous leukemia (AML): In vitro culture of AML cells - The present use in experimental studies and the possible importance for future therapeutic approaches, STEM CELLS, 19(1), 2001, pp. 1-11
Authors:
Bruserud, O
Tjonnfjord, G
Gjertsen, BT
Foss, B
Ernst, P
Citation: O. Bruserud et al., New strategies in the treatment of acute myelogenous leukemia: Mobilization and transplantation of autologous peripheral blood stem cells in adult patients (vol 18, pg 343, 2000), STEM CELLS, 19(1), 2001, pp. NIL_7-NIL_7
Authors:
Foss, B
Ulvestad, E
Bruserud, O
Citation: B. Foss et al., Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia:PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts, EUR J HAEMA, 66(6), 2001, pp. 365-376
Authors:
Foss, B
Abrahamsen, JF
Bruserud, O
Citation: B. Foss et al., Peripheral blood progenitor cell grafts contain high levels of platelet-secreted mediators, TRANSFUSION, 41(11), 2001, pp. 1431-1437
Authors:
Bruserud, O
Gjertsen, BT
Von Volkman, HL
Citation: O. Bruserud et al., In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: Studies of native AML blasts and AML cell lines, J HEMATH ST, 9(6), 2000, pp. 923-932
Authors:
Bruserud, O
Foss, B
Abrahamsen, JF
Gjertsen, BT
Ernst, P
Citation: O. Bruserud et al., Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: Does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?, J HEMATH ST, 9(4), 2000, pp. 433-443
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia, J INTERF CY, 20(11), 2000, pp. 947-954
Authors:
Bruserud, O
Ernst, P
Citation: O. Bruserud et P. Ernst, High dose Ara-C combined with autologous peripheral blood stem cell transplantation in the treatment of acute myelogenous leukemia: The question is still not answered, STEM CELLS, 18(6), 2000, pp. 459-460
Authors:
Bruserud, O
Tjonnfjord, G
Gjertsen, BT
Foss, B
Ernst, P
Citation: O. Bruserud et al., New strategies in the treatment of acute myelogenous leukemia: Mobilization and transplantation of autologous peripheral blood stem cells in adult patients, STEM CELLS, 18(5), 2000, pp. 343-351
Authors:
Bruserud, O
Gjertsen, BT
Citation: O. Bruserud et Bt. Gjertsen, New strategies for the treatment of acute myelogenous leukemia: Differentiation induction - Present use and future possibilities, STEM CELLS, 18(3), 2000, pp. 157-165
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels, CANCER IMMU, 49(7), 2000, pp. 377-387
Authors:
Bruserud, O
Citation: O. Bruserud, Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blastaccessory cells, INT J IMMUN, 22(1), 2000, pp. 69-81
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation, CELL IMMUN, 206(1), 2000, pp. 36-50
Authors:
Bruserud, O
von Volkman, HL
Ulvestad, E
Citation: O. Bruserud et al., The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: Characterization of T lymphocyte subsets responsive to IL-16 and IL-17, ACT HAEMAT, 104(2-3), 2000, pp. 80-91
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Effects of gamma-irradiation on acute myelogenous leukemia blasts: In vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation, J HEMATH ST, 8(4), 1999, pp. 431-441
Authors:
Bruserud, O
Frostad, S
Foss, B
Citation: O. Bruserud et al., In vitro culture of acute myelogenous leukemia blasts: A comparison of four different culture media, J HEMATOTH, 8(1), 1999, pp. 63-73
Authors:
Foss, B
Nesthus, I
Bergheim, J
Bruserud, O
Citation: B. Foss et al., Serum levels of thrombopoietin and stem cell factor in acute leukemia patients with chemotherapy-induced cytopenia and complicating infections, PLATELETS, 10(1), 1999, pp. 17-23
Authors:
Bassoe, CF
Halstensen, A
Bruserud, O
Citation: Cf. Bassoe et al., Functional differentiation of acute myeloid leukaemia blast cells, APMIS, 107(11), 1999, pp. 1023-1033
Authors:
Frostad, S
Bruserud, O
Citation: S. Frostad et O. Bruserud, In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts, EUR J HAEMA, 62(3), 1999, pp. 191-198
Authors:
Bruserud, O
Citation: O. Bruserud, Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies, LEUKEMIA, 13(8), 1999, pp. 1175-1187
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Expression and release of adhesion molecules by human acute myelogenous leukemia blasts, LEUK RES, 23(2), 1999, pp. 149-157